Correlation Between Amylyx Pharmaceuticals and Gossamer Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Amylyx Pharmaceuticals and Gossamer Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amylyx Pharmaceuticals and Gossamer Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amylyx Pharmaceuticals and Gossamer Bio, you can compare the effects of market volatilities on Amylyx Pharmaceuticals and Gossamer Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amylyx Pharmaceuticals with a short position of Gossamer Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amylyx Pharmaceuticals and Gossamer Bio.

Diversification Opportunities for Amylyx Pharmaceuticals and Gossamer Bio

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between Amylyx and Gossamer is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Amylyx Pharmaceuticals and Gossamer Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gossamer Bio and Amylyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amylyx Pharmaceuticals are associated (or correlated) with Gossamer Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gossamer Bio has no effect on the direction of Amylyx Pharmaceuticals i.e., Amylyx Pharmaceuticals and Gossamer Bio go up and down completely randomly.

Pair Corralation between Amylyx Pharmaceuticals and Gossamer Bio

Given the investment horizon of 90 days Amylyx Pharmaceuticals is expected to generate 2.6 times more return on investment than Gossamer Bio. However, Amylyx Pharmaceuticals is 2.6 times more volatile than Gossamer Bio. It trades about 0.13 of its potential returns per unit of risk. Gossamer Bio is currently generating about -0.54 per unit of risk. If you would invest  453.00  in Amylyx Pharmaceuticals on August 23, 2024 and sell it today you would earn a total of  66.00  from holding Amylyx Pharmaceuticals or generate 14.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Amylyx Pharmaceuticals  vs.  Gossamer Bio

 Performance 
       Timeline  
Amylyx Pharmaceuticals 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Amylyx Pharmaceuticals are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating essential indicators, Amylyx Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Gossamer Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Gossamer Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Amylyx Pharmaceuticals and Gossamer Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Amylyx Pharmaceuticals and Gossamer Bio

The main advantage of trading using opposite Amylyx Pharmaceuticals and Gossamer Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amylyx Pharmaceuticals position performs unexpectedly, Gossamer Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gossamer Bio will offset losses from the drop in Gossamer Bio's long position.
The idea behind Amylyx Pharmaceuticals and Gossamer Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Money Managers
Screen money managers from public funds and ETFs managed around the world